These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 4083863

  • 1. Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae.
    Swenson JM, Wallace RJ, Silcox VA, Thornsberry C.
    Antimicrob Agents Chemother; 1985 Dec; 28(6):807-11. PubMed ID: 4083863
    [Abstract] [Full Text] [Related]

  • 2. Multisite reproducibility of results obtained by the broth microdilution method for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum.
    Woods GL, Bergmann JS, Witebsky FG, Fahle GA, Wanger A, Boulet B, Plaunt M, Brown BA, Wallace RJ.
    J Clin Microbiol; 1999 Jun; 37(6):1676-82. PubMed ID: 10325306
    [Abstract] [Full Text] [Related]

  • 3. [Drug sensitivity analysis of Mycobacterium chelonae and Mycobacterium abscessus and evaluation of Etest for susceptibility testing].
    Gui J, Wang F, Hong CY, Li JL, Liang J.
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Aug; 36(8):567-71. PubMed ID: 24252731
    [Abstract] [Full Text] [Related]

  • 4. In Vitro Antimicrobial Susceptibility of Nontuberculous Mycobacteria in Iran.
    Heidarieh P, Mirsaeidi M, Hashemzadeh M, Feizabadi MM, Bostanabad SZ, Nobar MG, Hashemi Shahraki A.
    Microb Drug Resist; 2016 Mar; 22(2):172-8. PubMed ID: 26468990
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Evaluation of Antimicrobial Susceptibilities of Rapidly Growing Mycobacteria].
    Özkarataş MH, Arslan N, Esen N, Özkütük AA.
    Mikrobiyol Bul; 2023 Apr; 57(2):220-237. PubMed ID: 37067207
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. In vitro antimicrobial susceptibility testing of rapidly growing mycobacteria using the tablet diffusion method: resistance pattern of Norwegian Mycobacterium fortuitum and Mycobacterium chelonae isolates.
    Hoel T, Casals JB, Eng J.
    APMIS; 1993 Jan; 101(1):27-32. PubMed ID: 8457323
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. In vitro activity of the new quinolone RO 23-6240 (AM-833) and the new cephalosporins RO 15-8074 and RO 19-5247 (T-2525) against Mycobacterium fortuitum and Mycobacterium chelonae.
    Hohl P, Salfinger M, Kafader FM.
    Eur J Clin Microbiol; 1987 Aug; 6(4):487-8. PubMed ID: 3117539
    [No Abstract] [Full Text] [Related]

  • 11. Etest for routine clinical antimicrobial susceptibility testing of rapid-growing mycobacteria isolates.
    Koontz FP, Erwin ME, Barrett MS, Jones RN.
    Diagn Microbiol Infect Dis; 1994 Jul; 19(3):183-6. PubMed ID: 7821001
    [Abstract] [Full Text] [Related]

  • 12. In vitro susceptibilities of rapidly growing mycobacteria to newer antimicrobial agents.
    Khardori N, Nguyen H, Rosenbaum B, Rolston K, Bodey GP.
    Antimicrob Agents Chemother; 1994 Jan; 38(1):134-7. PubMed ID: 8141567
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of Etest for rapid susceptibility testing of Mycobacterium chelonae and M. fortuitum.
    Hoffner SE, Klintz L, Olsson-Liljequist B, Bolmström A.
    J Clin Microbiol; 1994 Aug; 32(8):1846-9. PubMed ID: 7989530
    [Abstract] [Full Text] [Related]

  • 14. Antimicrobial susceptibility testing of rapidly growing mycobacteria isolated in Japan.
    Hatakeyama S, Ohama Y, Okazaki M, Nukui Y, Moriya K.
    BMC Infect Dis; 2017 Mar 07; 17(1):197. PubMed ID: 28270102
    [Abstract] [Full Text] [Related]

  • 15. Effects of different test conditions on the susceptibility of Mycobacterium fortuitum and Mycobacterium chelonae to amikacin.
    Hansen KT, Clark RB, Sanders WE.
    J Antimicrob Chemother; 1994 Mar 07; 33(3):483-94. PubMed ID: 8040113
    [Abstract] [Full Text] [Related]

  • 16. Mutational resistance as the mechanism of acquired drug resistance to aminoglycosides and antibacterial agents in Mycobacterium fortuitum and Mycobacterium chelonei. Evidence is based on plasmid analysis, mutational frequencies, and aminoglycoside-modifying enzyme assays.
    Wallace RJ, Hull SI, Bobey DG, Price KE, Swenson JM, Steele LC, Christensen L.
    Am Rev Respir Dis; 1985 Aug 07; 132(2):409-16. PubMed ID: 4026065
    [Abstract] [Full Text] [Related]

  • 17. Comparison of the in vitro activity of the glycylcycline tigecycline (formerly GAR-936) with those of tetracycline, minocycline, and doxycycline against isolates of nontuberculous mycobacteria.
    Wallace RJ, Brown-Elliott BA, Crist CJ, Mann L, Wilson RW.
    Antimicrob Agents Chemother; 2002 Oct 07; 46(10):3164-7. PubMed ID: 12234839
    [Abstract] [Full Text] [Related]

  • 18. Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities.
    Wallace RJ, Swenson JM, Silcox VA, Bullen MG.
    J Infect Dis; 1985 Sep 07; 152(3):500-14. PubMed ID: 3875667
    [Abstract] [Full Text] [Related]

  • 19. CI-960 (PD127391 or AM-1091), sparfloxacin, WIN 57273, and isepamicin activity against clinical isolates of Mycobacterium avium-intracellularae complex, M. chelonae, and M. fortuitum.
    Barrett MS, Jones RN, Erwin ME, Koontz FP.
    Diagn Microbiol Infect Dis; 1992 Feb 07; 15(2):169-71. PubMed ID: 1315233
    [Abstract] [Full Text] [Related]

  • 20. In Vitro Susceptibility Testing of a Novel Benzimidazole, SPR719, against Nontuberculous Mycobacteria.
    Brown-Elliott BA, Rubio A, Wallace RJ.
    Antimicrob Agents Chemother; 2018 Nov 07; 62(11):. PubMed ID: 30126964
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.